TITLE

Hyphema Occurring During Selective Laser Trabeculoplasty

AUTHOR(S)
Shihadeh, Wisam A.; Ritch, Robert; Liebmann, Jeffrey M.
PUB. DATE
September 2006
SOURCE
Ophthalmic Surgery, Lasers & Imaging;Sep/Oct2006, Vol. 37 Issue 5, p432
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
The first case of hyphema occurring during selective laser trabeculoplasty in an eye without neovascularization is described. A 77-year-old man with uncontrolled open-angle glaucoma received selective laser trabeculoplasty in both eyes for high intraocular pressure with maximally tolerated medical treatment. Hyphema occurred during selective laser trabeculoplasty in the left eye. This resolved spontaneously without sequelae. Successful intraocular pressure control was achieved. Hyphema and bleeding can happen during selective laser trabeculoplasty. Although this was transient and uneventful in one patient, careful monitoring of intraocular pressure and anterior chamber reaction is advised.
ACCESSION #
22274622

 

Related Articles

  • Efficacy of Laser Trabeculoplasty in Phakic and Pseudophakic Patients With Primary Open-Angle Glaucoma. Mahdaviani, Sheila; Kitnarong, Naris; Kropf, Justin K.; Netland, Peter A. // Ophthalmic Surgery, Lasers & Imaging;Sep/Oct2006, Vol. 37 Issue 5, p394 

    BACKGROUND AND OBJECTIVE: To compare the efficacy of laser trabeculoplasty in pseudophakic and phakic patients with primary open-angle glaucoma (POAG). PATIENTS AND METHODS: Retrospective comparative case-control series of 42 eyes (21 pseudophakic eyes and 21 phakic eyes of patients matched for...

  • Research finds SLT all-around tool for glaucoma management. Guttman, Cheryl // Ophthalmology Times;1/15/2006, Vol. 31 Issue 2, p36 

    The article focuses on the results of a study showing that selective laser trabeculoplasty performed with the Q-switched frequency-doubled 532-nm Nd:YAG laser is a safe and effective option for lowering and maintaining intraocular pressure in glaucoma patients. Minimal side effects have been...

  • Lower energy levels adequate for effective transcleral diode laser cyclophotocoagulation in Asian eyes with refractory glaucoma. Kaushik, S.; Pandav, S. S.; Jain, R.; Bansal, S.; Gupta, A. // Eye;Mar2008, Vol. 22 Issue 3, p398 

    PurposeTo study the treatment parameters for diode laser cyclophotocoagulation (DLCP) in Asian Indian eyes using laser energy titrated to clinical response.MethodsThis prospective interventional longitudinal study included 66 eyes of 66 patients with varied aetiology refractory glaucoma, no...

  • Case report highlights rationale for neovascular glaucoma treatment. Kahook, Malik Y. // Ophthalmology Times;12/1/2006, Vol. 31 Issue 23, p43 

    The article discusses the study on the effectiveness of intravitreal bevacizumab for the treatment of neovascular glaucoma. The drug is an anti-vascular endothelial growth factor therapy which is currently approved for intravenous injection to treat colorectal cancer. According to the findings...

  • Cyclocryotherapy in neovascular glaucoma treatment. Janićijević-Petrović, Mirjana A.; Šarenac, Tatjana; Petrović, Marko; Vulović, Dejan; Janićijević, Katarina // Medicinski Glasnik;Feb2012, Vol. 9 Issue 1, p106 

    The main goal in the struggle with neovascular glaucoma is to control intraocular pressure (IOP) and pain. 152 patients, e.g., 203 eyes, were examined at the Clinic of Ophthalmology, Clinical Centre of Kragujevac, Serbia, in period between 01. 01. 2005 - 31. 12. 2010. Cyclocryoanemisatio was...

  • Low-energy SLT may be safer treatment option for reducing IOP.  // Ocular Surgery News;4/25/2011, Vol. 29 Issue 8, p23 

    The article offers information on the study regarding the effectivity of the lower-energy selective laser trabeculoplasty (SLT) for reducing intraocular pressure (IOP).

  • Managing the Narrow-angle Patient. Al-Aswad, Lama; Tsai, James C. // Review of Ophthalmology;Jun2004, Vol. 11 Issue 6, p45 

    Reports on the treatment of narrow-angle glaucoma patients with peripheral laser iridotomy. Risk factors for the development of primary angle-closure glaucoma; Common mechanisms involved in the disease; Need to re-examine the angle gonioscopically if the intraocular pressure is lower and the...

  • SLT: Big step forward for right patients. Charters, Lynda // Ophthalmology Times;10/15/2010, Vol. 35 Issue 20, p38 

    The article reports on the application of selective laser trabeculoplasty (SLT) as an effective procedure in glaucoma therapy and as the strongest anti-glaucoma medication. Garry P. Condon, professor at the Drexel University in Pennsylvania, also explains that the major advantage of SLT is the...

  • Longer follow-up data shed more light on risk factors for glaucoma progression. Groves, Nancy // Ophthalmology Times;5/15/2008, Vol. 33 Issue 10, p14 

    The article reports on the evaluation made by Early Manifest Glaucoma Trial (EMGT) on risk factors for glaucoma progression in New Orleans, Louisiana. Such trial is advantageous because it evaluates the effects of early intervention of glaucoma cases. Result from EGMT trial reveal that treatment...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics